Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation

This publication has 36 references indexed in Scilit:

• Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)
  Annals of Oncology, 2005
• Mobilizing peripheral blood stem cells with high‐dose G‐CSF alone is as effective as with Dexa‐BEAM plus G‐CSF in lymphoma patients
  British Journal of Haematology, 1998
• A Phase-II Study with Idarubicin, Ifosfamide and VP-16 (IIVP-16) in Patients with Refractory or Relapsed Aggressive and High Grade non-Hodgkin's Lymphoma
  Leukemia & Lymphoma, 1997
• The Role of Intensive Therapy and Autologous Blood and Marrow Transplantation for Chemotherapy‐Sensitive Relapsed and Primary Refractory Non‐Hodgkin’s Lymphoma: Identification of Major Prognostic Groups
  British Journal of Haematology, 1996
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995
• Pharmacological Properties of Oral Idarubicin
  Clinical Drug Investigation, 1995
• ISSUES IN BIOMEDICAL STATISTICS: ANALYSING 2 × 2 TABLES OF FREQUENCIES
  Anz Journal of Surgery, 1994
• A Comparative Analysis of the Sensitivity of Multidrug Resistant (MDR) and Non-MDR Cells to Different Anthracycline Derivatives
  Leukemia & Lymphoma, 1993
• Ifosfamide/Mesna
  Drugs, 1991
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958